NCT05817578

Brief Summary

The aim of this study is to collect a sum of different characteristics that have been mentioned previously in people presenting with RCRSP and by clustering them to create a phenotype system which may assist the individualisation of their management

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

September 2, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

1.1 years

First QC Date

April 5, 2023

Last Update Submit

June 19, 2023

Conditions

Keywords

Rotator Cuff Related Shoulder PainChronic Pain

Outcome Measures

Primary Outcomes (18)

  • Numeric Pain Rating Scale (NPRS)

    Obtain a measurement of pain Score: 0-10 Higher scores indicate more pain

    Once - Baseline

  • Western Ontario Rotator Cuff Index (WORC)

    Assess the self-reported functional ability of participants Score: 0-100 % Higher scores indicate higher functional status

    Once - Baseline

  • The Self-Report Leeds Assessment of Neuropathic Symptoms & Signs (SLANSS)

    Identify possible participants with neuropathic type of pain Score: 0-24 Score \>12 indicates neuropathic pain

    Once - Baseline

  • Central Sensitisation Inventory (CSI)

    Identify participants suspicious of central sensitisation symptoms Score: 0-100 Score\>40 indicates central sensitisation

    Once - Baseline

  • Pain Drawings (PD)

    Capture painful body locations for participants with the spectrum of pathologies

    Once - Baseline

  • Nociplastic Pain Flow Chart by IASP

    Identification of Predominant Pain Mechanism, especially participants with possible nociplastic pain

    Once - Baseline

  • Quantitative Sensory Testing (QST)

    Assessment of Pressure Pain Threshold, Conditioned Pain Modulation \& Temporal Summation

    Once - Baseline

  • Range of Motion (ROM)

    Assess Range of motion of the movements of interest

    Once - Baseline

  • Dynamometry

    Assess strength and explore pain provocation in participants

    Once - Baseline

  • Posterior Shoulder Endurance Test (PSET)

    Assess the endurance of the Rotator Cuff myotendinous unit

    Once - Baseline

  • Hospital Anxiety & Depression Scale (HADS)

    Obtain a score of Anxiety \& Depression among participants Score: 0-42 (Two scales between 0 \& 21 each - one for anxiety and 1 for depression) Higher Scores indicate higher anxiety \& depression

    Once - Baseline

  • Pain Catastrophising Scale (PCS)

    Explore how the pain experience is perceived by the individual Scale: 0-52 Higher scores indicate higher levels of catastrophising

    Once - Baseline

  • Tampa Scale of Kinesiophobia (TSK)

    Explore fear of movement and avoidance of participants Score: 17-68 Higher scores indicate higher levels of Kinesiophobia, cut-off point: scores \>37 are indicative of kinesiophobia

    Once - Baseline

  • Pain Self-Efficacy Questionnaire (PSEQ)

    Assess the ability of the participant to cope with a spectrum of activities Score: 0-60 Lower scores indicate less self-efficacy

    Once - Baseline

  • Allostatic Index-5 (ALI-5)

    Investigate psychosocial stressors reflective of chronc adaptive states for 'wear \& tear' of the human body Score: 0-5 Higher score indicating higher allostatic load

    Once - Baseline

  • EuroQol-5Dimension (EQ-5D)

    Investigate quality of life levels of participants Score: 5-likert with no problem, slight, moderate, severe and extreme in each of the dimensions plus the 0-100 VAS as a global rating of self-perceived health with higher scores indcating better health

    Once - Baseline

  • Pittsburgh Sleep Quality Index (PSQI)

    Assess sleep quality of participants Score: 0-21 Higher scores indicate worse sleep quality

    Once - Baseline

  • Modified Baecke Physical Activity Questionnaire (MBPAQ)

    Evaluate Physical Activity levels of participants Score: low - moderate - high Higher scores indicate higher activity levels

    Once - Baseline

Interventions

Testing procedures that follow previously used protocols of the literature for all the Quantitative Sensory Testing, Dynamometry \& Goniometry

Also known as: Dynamometry, Goniometry

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People in the 18-65 spectrum that have a gradual onset of shoulder pain without being able to recall any injuries to the area and pain to be present for at least three months

You may qualify if:

  • Age: 18-65
  • Pain: \>3 months, non-traumatic, unilateral or bilateral of anterolateral location
  • ROM: \>50% all planes, AROM painful in forward flexion and/or abduction
  • Provocation testing: Hawkins-Kennedy, Neer, Painful Arc, Resisted ER, Empty Can (3 or more out of the 5 +ve)

You may not qualify if:

  • Pain \< 3months
  • History of neck or shoulder trauma
  • Radicular signs, shoulder pain reproduced with neck movements
  • GH OA
  • Frozen Shoulder
  • Tears \>C3 according to Snyder Classification
  • Fibromyalgia
  • Neurological, systemic local or autoimmune inflammatory conditions
  • Clinical depression
  • No injected corticosteroids or physiotherapy the last 3/12

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Rotator Cuff InjuriesShoulder Impingement SyndromeRuptureChronic Pain

Interventions

Arthrometry, Articular

Condition Hierarchy (Ancestors)

Wounds and InjuriesShoulder InjuriesTendon InjuriesJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Range of Motion, ArticularPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • ELENI KAPRELI, PT, PROF

    University of Thessaly

    STUDY DIRECTOR

Central Study Contacts

ACHILLEAS PALIOURAS, PT, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Physiotherapist, MSc, PhD candidate

Study Record Dates

First Submitted

April 5, 2023

First Posted

April 18, 2023

Study Start

September 2, 2023

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

June 22, 2023

Record last verified: 2023-06